Pro Share Advisors LLC Amicus Therapeutics, Inc. Transaction History

Pro Share Advisors LLC

  • $39.7 Billion
  • Q3 2024

A detailed history of Pro Share Advisors LLC transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Pro Share Advisors LLC holds 72,972 shares of FOLD stock, worth $726,801. This represents 0.0% of its overall portfolio holdings.

Number of Shares
72,972
Previous 57,161 27.66%
Holding current value
$726,801
Previous $567,000 37.39%
% of portfolio
0.0%
Previous 0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$9.55 - $12.09 $150,995 - $191,154
15,811 Added 27.66%
72,972 $779,000
Q2 2024

Aug 13, 2024
SELL
$9.04 - $11.75 $141,783 - $184,287
-15,684 Reduced 21.53%
57,161 $567,000
Q1 2024

May 08, 2024
BUY
$11.43 - $14.24 $80,787 - $100,648
7,068 Added 10.75%
72,845 $858,000
Q4 2023

Feb 14, 2024
BUY
$9.97 - $14.52 $105,442 - $153,563
10,576 Added 19.16%
65,777 $933,000
Q3 2023

Nov 13, 2023
BUY
$11.78 - $13.86 $3,734 - $4,393
317 Added 0.58%
55,201 $671,000
Q2 2023

Aug 10, 2023
BUY
$10.72 - $13.3 $31,613 - $39,221
2,949 Added 5.68%
54,884 $689,000
Q1 2023

May 11, 2023
SELL
$10.91 - $13.54 $74,046 - $91,895
-6,787 Reduced 11.56%
51,935 $575,000
Q4 2022

Feb 02, 2023
BUY
$9.89 - $12.7 $46,730 - $60,007
4,725 Added 8.75%
58,722 $716,000
Q3 2022

Nov 04, 2022
BUY
$9.82 - $12.75 $11,892 - $15,440
1,211 Added 2.29%
53,997 $563,000
Q2 2022

Aug 01, 2022
SELL
$6.23 - $11.12 $158,908 - $283,637
-25,507 Reduced 32.58%
52,786 $566,000
Q1 2022

May 10, 2022
SELL
$7.89 - $12.48 $144,663 - $228,820
-18,335 Reduced 18.97%
78,293 $741,000
Q4 2021

Feb 08, 2022
BUY
$9.82 - $12.44 $58,772 - $74,453
5,985 Added 6.6%
96,628 $1.12 Million
Q3 2021

Nov 12, 2021
SELL
$8.74 - $11.84 $221,882 - $300,582
-25,387 Reduced 21.88%
90,643 $866,000
Q2 2021

Aug 13, 2021
BUY
$8.71 - $10.72 $97,412 - $119,892
11,184 Added 10.67%
116,030 $1.12 Million
Q1 2021

May 14, 2021
BUY
$9.2 - $23.86 $70,462 - $182,743
7,659 Added 7.88%
104,846 $1.04 Million
Q4 2020

Feb 09, 2021
BUY
$13.47 - $24.89 $327,671 - $605,474
24,326 Added 33.39%
97,187 $2.24 Million
Q3 2020

Nov 13, 2020
SELL
$12.89 - $15.89 $36,968 - $45,572
-2,868 Reduced 3.79%
72,861 $1.03 Million
Q2 2020

Aug 03, 2020
BUY
$8.86 - $15.69 $227,445 - $402,777
25,671 Added 51.28%
75,729 $1.14 Million
Q1 2020

May 15, 2020
SELL
$6.63 - $11.16 $263,409 - $443,386
-39,730 Reduced 44.25%
50,058 $463,000
Q4 2019

Feb 12, 2020
SELL
$7.48 - $10.75 $61,949 - $89,031
-8,282 Reduced 8.44%
89,788 $875,000
Q3 2019

Nov 12, 2019
BUY
$8.02 - $13.25 $47,005 - $77,658
5,861 Added 6.36%
98,070 $787,000
Q2 2019

Aug 13, 2019
SELL
$10.96 - $14.4 $47,895 - $62,928
-4,370 Reduced 4.52%
92,209 $1.15 Million
Q1 2019

May 15, 2019
BUY
$10.04 - $13.92 $125,700 - $174,278
12,520 Added 14.89%
96,579 $1.31 Million
Q4 2018

Feb 14, 2019
SELL
$8.38 - $13.44 $136,007 - $218,131
-16,230 Reduced 16.18%
84,059 $805,000
Q3 2018

Nov 14, 2018
SELL
$11.6 - $16.54 $44,694 - $63,728
-3,853 Reduced 3.7%
100,289 $1.21 Million
Q2 2018

Aug 13, 2018
SELL
$13.13 - $17.09 $72,385 - $94,217
-5,513 Reduced 5.03%
104,142 $1.63 Million
Q1 2018

May 14, 2018
SELL
$13.76 - $17.12 $64,809 - $80,635
-4,710 Reduced 4.12%
109,655 $1.65 Million
Q4 2017

Feb 14, 2018
BUY
$12.51 - $16.24 $129,040 - $167,515
10,315 Added 9.91%
114,365 $1.65 Million
Q3 2017

Nov 13, 2017
BUY
$11.74 - $15.78 $211,425 - $284,182
18,009 Added 20.93%
104,050 $1.57 Million
Q2 2017

Aug 11, 2017
BUY
N/A
86,041
86,041 $866,000

Others Institutions Holding FOLD

# of Institutions
313
Shares Held
314M
Call Options Held
516K
Put Options Held
833K
View Full List

About AMICUS THERAPEUTICS, INC.

FOLD Quotes by TradingView
  • Ticker FOLD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 280,497,984
  • Market Cap $2.79B
  • Description
  • Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...
More about FOLD
Track This Portfolio

Track Pro Share Advisors LLC Portfolio

Follow Pro Share Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email